Skip to main content
. 2018 Aug 7;13(5):557–572. doi: 10.1080/15592294.2018.1481703

Figure 6.

Figure 6.

A schematic illustration of the mechanism of KDM4B inhibition-mediated immunosuppression. KDM4B activity inactivates KDM1A and allows for active transcription of pro-inflammatory cytokines while KDM4B inhibition allows for active demethylation by KDM1A, reducing pro-inflammatory cytokine production.